BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
Business/Source-attributed reporting

Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers like India won't be easy.

The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers like India won't be easy.
ORIGINAL SOURCE

Consumer News and Business Channel

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗